South Florida's Access to Affordable Prescription Drugs
South Florida's Access to Affordable Prescription Drugs

Author: James C. Greenwood

Publisher:

Published: 2005-10-01

Total Pages: 90

ISBN-13: 9781422301586

DOWNLOAD EBOOK

Witnesses: Resi Coplan; Ellitt Hahn, Chmn. & Pres., Andrx Corp.; Michael A. Jackson, Exec. V.P., Florida Pharmacy Assoc.; Bentley Lipscomb, State Dir., AARP; Robert N. McEwan, CEO, Medbank of Maryland, Inc.; Carlos A. Ruiz, Pharmacy Dir., Navarro Discount Pharmacies; Gene Sweed; John D. Taylor, Drug Inspector, Florida Dept. of Health, Bureau of Statewide Pharmaceutical Services; & John M. Taylor, Assoc. Commr. of Regulatory Affairs, Food & Drug Admin. (FDA). Charts & tables.

House Hearing, 108th Congress
House Hearing, 108th Congress

Author: U. S. Government Printing Office (Gpo)

Publisher: BiblioGov

Published: 2013-09

Total Pages: 94

ISBN-13: 9781289373856

DOWNLOAD EBOOK

The United States Government Printing Office (GPO) was created in June 1860, and is an agency of the U.S. federal government based in Washington D.C. The office prints documents produced by and for the federal government, including Congress, the Supreme Court, the Executive Office of the President and other executive departments, and independent agencies. A hearing is a meeting of the Senate, House, joint or certain Government committee that is open to the public so that they can listen in on the opinions of the legislation. Hearings can also be held to explore certain topics or a current issue. It typically takes between two months up to two years to be published. This is one of those hearings.

Making Medicines Affordable
Making Medicines Affordable

Author: National Academies of Sciences, Engineering, and Medicine

Publisher: National Academies Press

Published: 2018-03-01

Total Pages: 235

ISBN-13: 0309468086

DOWNLOAD EBOOK

Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.